LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanding Funding Verastem Oncology recently secured a significant $90 million public offering and a $150 million credit facility, indicating strong financial backing and potential for increased investment in research and development activities.

Strategic Partnerships The company's collaborations with Tempus and IQVIA highlight opportunities to support targeted diagnostics and launch strategies for their investigational drugs, creating avenues for co-marketing, distribution, and diagnostic integration collaborations.

Focused Market Niche Specializing in RAS/MAPK pathway-driven cancers with a pipeline targeting KRAS G12D, RAF/MEK, and FAK inhibition, Verastem offers a specialized product portfolio ideal for healthcare providers seeking novel therapies in oncology markets.

Leadership Expansion The recent appointment of a Chief Operating Officer and active participation in industry conferences signal a growing and dynamic leadership team, positioning the company for accelerated market entry and outreach efforts.

Research & Development Focus With ongoing data presentations at major oncology conferences and a pipeline centered on innovative small molecule inhibitors, Verastem presents opportunities to engage with research institutions and clinical trials seeking novel oncology solutions.

Verastem Oncology Tech Stack

Verastem Oncology uses 8 technology products and services including Moat, Tableau, Microsoft PowerPoint, and more. Explore Verastem Oncology's tech stack below.

  • Moat
    Analytics
  • Tableau
    Business Intelligence
  • Microsoft PowerPoint
    Editors
  • Apple iCloud Mail
    Email
  • Backbone.js
    Javascript Frameworks
  • Slider Revolution
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Contact Form 7
    Web Platform Extensions

Media & News

Verastem Oncology's Email Address Formats

Verastem Oncology uses at least 1 format(s):
Verastem Oncology Email FormatsExamplePercentage
FLast@verastem.comJDoe@verastem.com
90%
FirstLast@verastem.comJohnDoe@verastem.com
7%
Last@verastem.comDoe@verastem.com
2%
FirLast@verastem.comJohDoe@verastem.com
1%

Frequently Asked Questions

Where is Verastem Oncology's headquarters located?

Minus sign iconPlus sign iconVerastem Oncology's main headquarters is located at 117 Kendrick Street, Suite 500 Needham, Massachusetts 02494, US. The company has employees across 1 continents, including North America.

What is Verastem Oncology's phone number?

Minus sign iconPlus sign icon You can contact Verastem Oncology's main corporate office by phone at
+1-617-252-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Verastem Oncology's stock symbol?

Minus sign iconPlus sign iconVerastem Oncology is a publicly traded company; the company's stock symbol is VSTM.

What is Verastem Oncology's official website and social media links?

Minus sign iconPlus sign iconVerastem Oncology's official website is verastem.com and has social profiles on LinkedIn.

What is Verastem Oncology's SIC code NAICS code?

Minus sign iconPlus sign iconVerastem Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Verastem Oncology have currently?

Minus sign iconPlus sign iconAs of October 2025, Verastem Oncology has approximately 128 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: J. P.Chief Commercial And Business Officer (ccbo: M. C.Chief Medical Officer: J. H.. Explore Verastem Oncology's employee directory with LeadIQ.

What industry does Verastem Oncology belong to?

Minus sign iconPlus sign iconVerastem Oncology operates in the Biotechnology Research industry.

What technology does Verastem Oncology use?

Minus sign iconPlus sign iconVerastem Oncology's tech stack includes MoatTableauMicrosoft PowerPointApple iCloud MailBackbone.jsSlider RevolutionMicrosoftContact Form 7.

What is Verastem Oncology's email format?

Minus sign iconPlus sign iconVerastem Oncology's email format typically follows the pattern of FLast@verastem.com. Find more Verastem Oncology email formats with LeadIQ.

When was Verastem Oncology founded?

Minus sign iconPlus sign iconVerastem Oncology was founded in 2010.
Verastem Oncology

Verastem Oncology

Biotechnology ResearchUnited States51-200 Employees

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition. 

Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS/MAPK pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com.

X/Twitter:      @VerastemOncolog

Section iconCompany Overview

Headquarters
117 Kendrick Street, Suite 500 Needham, Massachusetts 02494, US
Phone number
+1-617-252-****
Website
verastem.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
VSTM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $50M$100M

    Verastem Oncology's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Verastem Oncology's revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    J. P.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. C.
    Chief Commercial And Business Officer (ccbo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. H.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. J.
    Chief Information Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. R.
    Chief Operating Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    D. P.
    President And Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. C.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. C.
    Chief Organization Effectiveness Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. P.
    Strategic Account Director - Gpo/Organized Customers
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. L.
    Chief Medical Officer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.